1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) CM355 - Hematoma | Phase 1 / Phase 2 | Active not recruiting | Beijing InnoCare Pharma Tech Co., Ltd. | 184 | 2021-11-16 | 2022-01-27 |
Hemorrhage (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Beijing InnoCare Pharma Tech Co., Ltd. (1)
China (1)
Yuqin Song, M.D. (1)